References
- Holmes GP, Kaplan JE, Gantz NM, et al. Chronic fatigue syndrome: a working case definition. Ann Intern Med. 1988;108:387–389. doi: https://doi.org/10.7326/0003-4819-108-3-387
- Fukuda K, Straus SE, Hickie I, et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International chronic fatigue syndrome study group. Ann Intern Med. 1994;121:953–959. doi: https://doi.org/10.7326/0003-4819-121-12-199412150-00009
- Carruthers BM, Jain AK, De Meirleir KL, et al. Myalgic encephalomyelitis/chronic fatigue syndrome: clinical working case definition, diagnostic and treatment protocols. J Chronic Fatigue Syndr. 2003;11:7–115. doi: https://doi.org/10.1300/J092v11n01_02
- Institute of Medicine (IOM). Beyond myalgic encephalomyelitis/chronic fatigue syndrome. Redifining an illness. Washington (DC): The National Academies Press; 2015.
- Haney E, Smith ME, McDonagh M, et al. Diagnostic methods for myalgic encephalomyelitis/chronic fatigue syndrome: a systematic review for a National Institutes of Health pathways to prevention workshop. Ann Intern Med. 2015;162:834–840. doi: https://doi.org/10.7326/M15-0443
- Jason LA, Katz BZ, Shiraishi Y, et al. Predictors of post-infectious chronic fatigue syndrome in adolescents. Health Psychol Behav Med. 2014;2:41–51. doi: https://doi.org/10.1080/21642850.2013.869176
- Katz BZ, Shiraishi Y, Mears CJ, et al. Chronic fatigue syndrome after infectious mononucleosis in adolescents. Pediatrics. 2009;124:189–193. doi: https://doi.org/10.1542/peds.2008-1879
- Hickie I, Davenport T, Wakefield D, et al. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. Br Med J. 2006;333(7568):575. doi: https://doi.org/10.1136/bmj.38933.585764.AE
- White PD, Thomas JM, Amess J, et al. Incidence, risk and prognosis of acute and chronic fatigue syndromes and psychiatric disorders after glandular fever. Br J Psychiatr. 1998;173:475–481. doi: https://doi.org/10.1192/bjp.173.6.475
- Eriksen W. The spread of EBV to ectopic lymphoid aggregates may be the final common pathway in the pathogenesis of ME/CFS. Med Hypotheses. 2017;102:8–15. doi: https://doi.org/10.1016/j.mehy.2017.02.011
- Kogelnik AM, Loomis K, Hoegh-Petersen M, et al. Use of valganciclovir in patients with elevated antibody titers against Human Herpesvirus-6 (HHV-6) and Epstein-Barr Virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue. J Clin Virol. 2006;37(Suppl 1):S33–S38. doi: https://doi.org/10.1016/S1386-6532(06)70009-9
- Lerner AM, Beqaj SH, Deeter RG, et al. Igm serum antibodies to Epstein-Barr virus are uniquely present in a subset of patients with the chronic fatigue syndrome. In Vivo. 2004;18:101–106.
- Daugherty SA, Henry BE, Peterson DL, et al. Chronic fatigue syndrome in Northern Nevada. Rev Infect Dis. 1991;13(Suppl 1):S39–S44. doi: https://doi.org/10.1093/clinids/13.Supplement_1.S39
- Soto NE, Straus SE. Chronic fatigue syndrome and herpesviruses: the fading evidence. Herpes. 2000;7(2):46–50.
- Katz B. Update on chronic fatigue syndrome and Epstein-Barr virus. Pediatr Ann. 2002;31:741–744. doi: https://doi.org/10.3928/0090-4481-20021101-10
- Hjalgrim H, Friborg J, Melbye M. The epidemiology of EBV and its association with malignant disease. Chapter 53. In Arvin A, Campadelli-Fiume G, Mocarski E, et al., editors. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge: Cambridge University Press; 2007.
- Balfour HH Jr, Sifakis F, Sliman JA, et al. Age-specific prevalence of Epstein-Barr Virus infection among individuals aged 6–19 years in the United States and factors affecting its acquisition. J Infect Dis. 2013;208:1286–1293. doi: https://doi.org/10.1093/infdis/jit321
- Dowd JB, Palermo T, Brite J, et al. Seroprevalence of Epstein-Barr virus infection in US children ages 6–19, 2003–2010. PLoS One. 2013;8:e64921. doi: https://doi.org/10.1371/journal.pone.0064921
- Odumade OA, Hogquist KA, Balfour HH Jr. Progress and problems in understanding and managing primary Epstein-Barr virus infections. Clin Microbiol Rev. 2011;24:193–209. doi: https://doi.org/10.1128/CMR.00044-10
- De Paschale M, Clerici P. Serological diagnosis of Epstein-Barr virus infection: problems and solutions. World J Virol. 2012;1:31–43. doi: https://doi.org/10.5501/wjv.v1.i1.31
- Thorley-Lawson DA. EBV persistence – introducing the virus. Curr Top Microbiol Immunol. 2015;390:151–209.
- Cohen JI, Jaffe ES, Dale JK, et al. Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States. Blood. 2011;117:5835–5849. doi: https://doi.org/10.1182/blood-2010-11-316745
- Savoldo B, Huls MH, Liu Z, et al. Autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for the treatment of persistent active EBV infection. Blood. 2002;100:4059–4066. doi: https://doi.org/10.1182/blood-2002-01-0039
- Lerner AM, Beqaj S. Abortive lytic Epstein-Barr virus replication in tonsil-B lymphocytes in infectious mononucleosis and a subset of the chronic fatigue syndrome. Virus Adapt Treat. 2012;4:85–91. doi: https://doi.org/10.2147/VAAT.S36540
- Lerner AM, Ariza ME, Williams M, et al. Antibody to Epstein-Barr virus deoxyuridine triphosphate nucleotidohydrolase and deoxyribonucleotide polymerase in a chronic fatigue syndrome subset. PLoS One. 2012;7:e47891. doi: https://doi.org/10.1371/journal.pone.0047891
- Komaroff AL, Buchwald DS. Chronic fatigue syndrome: an update. Annu Rev Med. 1998;49:1–13. doi: https://doi.org/10.1146/annurev.med.49.1.1
- Jones JF. Serologic and immunologic responses in chronic fatigue syndrome with emphasis on the Epstein-Barr virus. Rev Infect Dis. 1991;13(Suppl 1):S26–S31. doi: https://doi.org/10.1093/clinids/13.Supplement_1.S26
- Komaroff AL, Cho TA. Role of infection and neurologic dysfunction in chronic fatigue syndrome. Semin Neurol. 2011;31:325–337. doi: https://doi.org/10.1055/s-0031-1287654
- Sairenji T, Yamanishi K, Tachibana Y, et al. Antibody responses to Epstein-Barr virus, human herpesvirus 6 and human herpesvirus 7 in patients with chronic fatigue syndrome. Intervirology. 1995;38:269–273. doi: https://doi.org/10.1159/000150450
- Mawle AC, Nisenbaum R, Dobbins JG, et al. Seroepidemiology of chronic fatigue syndrome: a case-control study. Clin Infect Dis. 1995;21(6):1386–1389. doi: https://doi.org/10.1093/clinids/21.6.1386
- Whelton CL, Salit I, Moldofsky H. Sleep, Epstein-Barr virus infection, musculoskeletal pain, and depressive symptoms in chronic fatigue syndrome. J Rheumatol. 1992;19:939–943.
- Manian FA. Simultaneous measurement of antibodies to Epstein-Barr virus, human herpesvirus 6, herpes simplex virus types 1 and 2, and 14 enteroviruses in chronic fatigue syndrome: is there evidence of activation of a nonspecific polyclonal immune response? Clin Infect Dis. 1994;19:448–453. doi: https://doi.org/10.1093/clinids/19.3.448
- Ikuta K, Yamada T, Shimomura T, et al. Diagnostic evaluation of 2’,5’-oligoadenylate synthetase activities and antibodies against Epstein-Barr virus and Coxiella burnetii in patients with chronic fatigue syndrome in Japan. Microbes Infect. 2003;5:1096–1102. doi: https://doi.org/10.1016/j.micinf.2003.07.002
- Kawai K, Kawai A. Studies on the relationship between chronic fatigue syndrome and Epstein-Barr virus in Japan. Intern Med. 1992;31:313–318. doi: https://doi.org/10.2169/internalmedicine.31.313
- Natelson BH, Ye N, Moul DE, et al. High titers of anti-Epstein-Barr virus DNA polymerase are found in patients with severe fatiguing illness. J Med Virol. 1994;42:42–46. doi: https://doi.org/10.1002/jmv.1890420109
- Tedeschi R, Foong YT, Cheng HM, et al. The disease associations of the antibody response against the Epstein-Barr virus transactivator protein ZEBRA can be separated into different epitopes. J Gen Virol. 1995;76:1393–1400. doi: https://doi.org/10.1099/0022-1317-76-6-1393
- Hotchin NA, Read R, Smith DG, et al. Active Epstein-Barr virus infection in post-viral fatigue syndrome. J Infect. 1989;18:143–150. doi: https://doi.org/10.1016/S0163-4453(89)91150-X
- Schmaling KB, Jones JF. MMPI profiles of patients with chronic fatigue syndrome. J Psychosom Res. 1996;40:67–74. doi: https://doi.org/10.1016/0022-3999(95)00543-9
- Buchwald D, Ashley RL, Pearlman T, et al. Viral serologies in patients with chronic fatigue and chronic fatigue syndrome. J Med Virol. 1996;50:25–30. doi: https://doi.org/10.1002/(SICI)1096-9071(199609)50:1<25::AID-JMV6>3.0.CO;2-V
- Zhang L, Gough J, Christmas D, et al. Microbial infections in eight genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis. J Clin Pathol. 2010;63:156–164. doi: https://doi.org/10.1136/jcp.2009.072561
- Wallace HL, Natelson B, Gause W, et al. Human herpesviruses in chronic fatigue syndrome. Clin Diagn Lab Immunol. 1999;6:216–223.
- White PD, Thomas JM, Kangro HO, et al. Predictions and associations of fatigue syndromes and mood disorders that occur after infectious mononucleosis. Lancet. 2001;358:1946–1954. doi: https://doi.org/10.1016/S0140-6736(01)06961-6
- Hilgers A, Frank J. Chronic fatigue syndrome: evaluation of a 30-criteria-score and correlation with immune activation. J Chronic Fatigue Syndr. 1996;2(4):35–47. doi: https://doi.org/10.1300/J092v02n04_04
- Patnaik M, Komaroff AL, Conley E, et al. Prevalence of IgM antibodies to human herpesvirus 6 early antigen (p41/38) in patients with chronic fatigue syndrome. J Infect Dis. 1995;172:1364–1367. doi: https://doi.org/10.1093/infdis/172.5.1364
- Loebel M, Strohschein K, Giannini C, et al. Deficient EBV-specific B- and T-cell response in patients with chronic fatigue syndrome. PLoS One. 2014;9:e85387. doi: https://doi.org/10.1371/journal.pone.0085387
- Loebel M, Eckey M, Sotzny F, et al. Serological profiling of the EBV immune response in chronic fatigue syndrome using a peptide microarray. PLoS One. 2017;12:e0179124. doi: https://doi.org/10.1371/journal.pone.0179124
- Halpin P, Williams MV, Klimas NG, et al. Myalgic encephalomyelitis/chronic fatigue syndrome and gulf war illness patients exhibit increased humoral responses to the herpesviruses-encoded dUTPase: implications in disease pathophysiology. J Med Virol. 2017;89:1636–1645. doi: https://doi.org/10.1002/jmv.24810
- Swanink CMA, Vercoulen JHMM, Bleijenberg G, et al. Chronic fatigue syndrome: a clinical and laboratory study with a well matched control group. J Intern Med. 1995;237:499–506. doi: https://doi.org/10.1111/j.1365-2796.1995.tb00876.x
- Woodward CG, Cox RA. Epstein-Barr virus serology in the chronic fatigue syndrome. J Infect. 1992;24(2):133–139. doi: https://doi.org/10.1016/0163-4453(92)92772-B
- Levine PH, Jacobson S, Pocinki AG, et al. Clinical, epidemiologic, and virologic studies in four clusters of the chronic fatigue syndrome. Arch Intern Med. 1992;152:1611–1616. doi: https://doi.org/10.1001/archinte.1992.00400200049009
- Cameron B, Bharadwaj M, Burrows J, et al. Prolonged illness after infectious mononucleosis is associated with altered immunity but not with increased viral load. J Infect Dis. 2006;193:664–671. doi: https://doi.org/10.1086/500248
- Cameron B, Flamand L, Juwana H, et al. Serological and virological investigation of the role of the herpesviruses EBV, CMV and HHV-6 in post-infective fatigue syndrome. J Med Virol. 2010;82:1684–1688. doi: https://doi.org/10.1002/jmv.21873
- Smith MS, Mitchell J, Corey L, et al. Chronic fatigue in adolescents. Pediatrics. 1991;88:195–202.
- Gow JW, Behan WMH, Clements GB, et al. Enteroviral RNA sequences detected by polymerase chain reaction in muscle of patients with postviral fatigue syndrome. Br Med J. 1991;302:692–696. doi: https://doi.org/10.1136/bmj.302.6778.692
- Buchwald D, Cheney PR, Peterson DL, et al. A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection. Ann Intern Med. 1992;116:103–113. doi: https://doi.org/10.7326/0003-4819-116-2-103
- Gold D, Bowden R, Sixbey J, et al. Chronic fatigue. A prospective clinical and virologic study. JAMA. 1990;264:48–53. doi: https://doi.org/10.1001/jama.1990.03450010052029
- Jones JF, Williams M, Schooley RT, et al. Antibodies to Epstein-Barr virus-specific DNase and DNA polymerase in the chronic fatigue syndrome. Arch Intern Med. 1988;148:1957–1960. doi: https://doi.org/10.1001/archinte.1988.00380090047012
- Wray BB, Gaughf C, Chandler FW Jr, et al. Detection of Epstein-Barr virus and cytomegalovirus in patients with chronic fatigue. Ann Allergy. 1993;71:223–226.
- Swanink CMA, van der Meer JWM, Vercoulen JHMM, et al. Epstein-Barr virus (EBV) and the chronic fatigue syndrome: normal virus load in blood and normal immunologic reactivity in the EBV regression assay. Clin Infect Dis. 1995;20:1390–1392. doi: https://doi.org/10.1093/clinids/20.5.1390
- Frémont M, Metzger K, Rady H, et al. Detection of herpesviruses and Parvovirus B19 in gastric and intestinal mucosa of chronic fatigue syndrome patients. In Vivo. 2009;23:209–214.
- Koelle DM, Barcy S, Meei-Li H, et al. Markers of viral infection in monozygotic twins discordant for chronic fatigue syndrome. Clin Infect Dis. 2002;35:518–525. doi: https://doi.org/10.1086/341774
- Jones JF, Streib J, Baker S, et al. Chronic fatigue syndrome: I. Epstein-Barr virus immune response and molecular epidemiology. J Med Virol. 1991;33:151–158. doi: https://doi.org/10.1002/jmv.1890330303
- Cunningham L, Bowles NE, Archard LC. Persistent virus infection of muscle in postviral fatigue syndrome. Br Med Bull. 1991;47:852–871. doi: https://doi.org/10.1093/oxfordjournals.bmb.a072516
- Gascón J, Marcos T, Vidal J, et al. Cytomegalovirus and Epstein-Barr virus infection as a cause of chronic fatigue syndrome in travelers to tropical countries. J Travel Med. 1995;2:41–44. doi: https://doi.org/10.1111/j.1708-8305.1995.tb00619.x
- Carver LA, Connallon PF, Flanigan SJ, et al. Epstein-Barr virus infection in Desert Storm reservists. Mil Med. 1994;159:580–582. doi: https://doi.org/10.1093/milmed/159.8.580
- Hilgers A, Krueger GRF, Lembke U, et al. Postinfectious chronic fatigue syndrome: case history of thirty-five patients in Germany. In Vivo. 1991;5:201–206.
- Petrov D, Marchalik D, Sosin M, et al. Factors affecting duration of chronic fatigue syndrome in pediatric patients. Indian J Pediatr. 2012;79:52–55. doi: https://doi.org/10.1007/s12098-011-0463-4
- Eymard D, Lebel F, Miller M, et al. Human herpesvirus 6 and chronic fatigue syndrome. Can J Infect Dis. 1993;4:199–202. doi: https://doi.org/10.1155/1993/414602
- Wagner M, Krueger GRF, Ablashi DV, et al. Chronic fatigue syndrome (CFS): a critical evaluation of testing for active human herpesvirus-6 (HHV-6) infection. J Chronic Fatigue Syndr. 1996;2:3–16. doi: https://doi.org/10.1300/J092v02n04_02
- Preedy VR, Smith DG, Salisbury JR, et al. Biochemical and muscle studies in patients with acute onset post-viral fatigue syndrome. J Clin Pathol. 1993;46:722–726. doi: https://doi.org/10.1136/jcp.46.8.722
- Gupta S, Vayuvegula B. A comprehensive immunological analysis in chronic fatigue syndrome. Scand J Immunol. 1991;33:319–327. doi: https://doi.org/10.1111/j.1365-3083.1991.tb01777.x
- Marshall GS, Gesser RM, Yamanishi K, et al. Chronic fatigue in children: clinical features, Epstein-Barr virus and human herpesvirus 6 serology and long term follow-up. Pediatr Infect Dis J. 1991;10:287–290. doi: https://doi.org/10.1097/00006454-199104000-00004
- Levine S. Prevalence in the cerebrospinal fluid of the following infectious agents in a cohort of 12 CFS subjects: Human Herpes Virus-6 and 8; Chlamydia species; Mycoplasma species; EBV; CMV; and Coxsackievirus. J Chronic Fatigue Syndr. 2001;9:41–51. doi: https://doi.org/10.1300/J092v09n01_05
- Matthews DA, Lane TJ, Manu P. Antibodies to Epstein-Barr virus in patients with chronic fatigue. South Med J. 1991;84:832–840. doi: https://doi.org/10.1097/00007611-199107000-00005
- Hellinger WC, Smith TF, Van Scoy RE, et al. Chronic fatigue syndrome and the diagnostic utility of antibody to Epstein-Barr virus early antigen. JAMA. 1988;260:971–973. doi: https://doi.org/10.1001/jama.1988.03410070099036
- Carter BD, Edwards JF, Kronenberger WG, et al. Case control study of chronic fatigue in pediatric patients. Pediatrics. 1995;95:179–186.
- Read R, Larson E, Harvey J, et al. Clinical and laboratory findings in the Paul-Bunnel negative glandular fever-fatigue syndrome. J Infect. 1990;21:157–165. doi: https://doi.org/10.1016/0163-4453(90)91675-4
- Buchwald DS, Rea TD, Katon WJ, et al. Acute infectious mononucleosis: characteristics of patients who report failure to recover. Am J Med. 2000;109:531–537. doi: https://doi.org/10.1016/S0002-9343(00)00560-X
- Schluederberg A, Straus SE, Peterson P, et al. Chronic fatigue syndrome research. Definition and medical outcome assessment. Ann Intern Med. 1992;117:325–331. doi: https://doi.org/10.7326/0003-4819-117-4-325
- Sharpe MC, Archard LC, Banatvala JE, et al. A report – chronic fatigue syndrome: guidelines for research. J R Soc Med. 1991;84:118–121. doi: https://doi.org/10.1177/014107689108400224
- Tugizov S, Herrera R, Veluppillai P, et al. Epstein-Barr virus (EBV)-infected monocytes facilitate dissemination of EBV within the oral mucosal epithelium. J Virol. 2007;81:5484–5496. doi: https://doi.org/10.1128/JVI.00171-07
- Coleman CB, Wohlford EM, Smith NA, et al. Epstein-Barr virus Type 2 latently infects T cells, inducing an atypical activation characterized by expression of lymphotactic cytokines. J Virol. 2015;89:2301–2312. doi: https://doi.org/10.1128/JVI.03001-14
- Lucchesi D, Bombardieri M. The role of viruses in autoreactive B cell activation within tertiary lymphoid structures in autoimmune diseases. J Leukoc Biol. 2013;94:1191–1199. doi: https://doi.org/10.1189/jlb.0413240
- Serafini B, Rosicarelli B, Franciotta D, et al. Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J Exp Med. 2007;204:2899–2912. doi: https://doi.org/10.1084/jem.20071030
- Montoya JG, Kogelnik AM, Bhangoo M, et al. Randomized clinical trial to evaluate the efficacy and safety of valganciclovir in a subset of patients with chronic fatigue syndrome. J Med Virol. 2013;85:2101–2109. doi: https://doi.org/10.1002/jmv.23713
- Lerner AM, Beqaj SH, Deeter RG, et al. Valacyclovir treatment in Epstein-Barr virus subset chronic fatigue syndrome: thirty-six months follow-up. In Vivo. 2007;21:707–714.
- Wu C-C, Fang C-Y, Cheng Y-J, et al. Inhibition of Epstein-Barr virus reactivation by the flavonoid apigenin. J Biomed Sci. 2017;24:2. doi: https://doi.org/10.1186/s12929-016-0313-9
- Pender MP, Csurhes PA, Smith C, et al. Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis. Multiple Sclerosis J. 2014;20:1541–1544. doi: https://doi.org/10.1177/1352458514521888
- Messick TE, Soldan SS, Deakyne J, et al. Development of a small molecule drug for EBV-associated gastric cancers. J Clin Oncol. 2017;35(Suppl 4):63. doi: https://doi.org/10.1200/JCO.2017.35.4_suppl.63
- Pender MP. CD8+ T-cell deficiency, Epstein-Barr virus infection, vitamin D deficiency, and steps to autoimmunity: a unifying hypothesis. Autoimmune Dis. 2012;2012:189096.
- Orange JS. Natural killer cell deficiency. J Allergy Clin Immunol. 2013;132:515–525. doi: https://doi.org/10.1016/j.jaci.2013.07.020
- Strayer D, Scott V, Carter W. Low NK cell activity in chronic fatigue syndrome (CFS) and relationship to symptom severity. J Clin Cell Immunol. 2015;6:4.
- Maher KJ, Klimas NG, Fletcher MA. Chronic fatigue syndrome is associated with diminished intracellular perforin. Clin Exp Immunol. 2005;142:505–511.
- Sotzny F, Blanco J, Capelli E, et al. Myalgic eencephalomyelitis/chronic fatigue syndrome – evidence for an autoimmune disease. Autoimmun Rev. 2018;17:601–609. doi: https://doi.org/10.1016/j.autrev.2018.01.009
- Fluge Ø, Bruland O, Risa K, et al. Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study. PLoS One. 2011;6:e26358. doi: https://doi.org/10.1371/journal.pone.0026358
- Harley JB, Chen X, Pujato M, et al. Transcription factors operate across disease loci, with EBNA2 implicated in autoimmunity. Nat Genet. 2018;50:699–707. doi: https://doi.org/10.1038/s41588-018-0102-3